Literature DB >> 18337152

Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck.

Maria Aguirregomozcorta1, Javier Pagonabarraga, Jordi Diaz-Manera, Berta Pascual-Sedano, Alexandre Gironell, Jaime Kulisevsky.   

Abstract

Severe dystonic tics involving the neck may lead to the development of serious spine disease. The pharmacological treatment of tics offers symptomatic relief, but clinically relevant improvement of severe tics is not frequently achieved and serious adverse events may result. Botulinum toxin (BnT) appears to be a safe and effective treatment for tics, but some concern exists about which group of patients may benefit from treatment. We report a patient affected by Tourette syndrome with tetraparesis and cervical myelopathy secondary to violent dystonic tics involving the neck, in which a more aggressive course of treatment with BnT in addition to neuroleptic medication resulted in complete resolution of cervical tics after 12 months of follow-up.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337152     DOI: 10.1016/j.parkreldis.2007.10.007

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Cervical spondylotic myelopathy caused by violent motor tics in a child with Tourette syndrome.

Authors:  Da-Young Ko; Seung-Ki Kim; Jong-Hee Chae; Kyu-Chang Wang; Ji Hoon Phi
Journal:  Childs Nerv Syst       Date:  2012-10-07       Impact factor: 1.475

2.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

Review 3.  Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Authors:  Sanjay Pandey; Prachaya Srivanitchapoom; Richard Kirubakaran; Brian D Berman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-05

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

5.  Progressive Cervical Spondylotic Myelopathy Caused by Tic Disorders in a Young Adult with Tourette Syndrome.

Authors:  Jonggil Kim; Ji-Yoon Kim; Ja Myoung Lee; Dong Ho Kang; Chul Hee Lee; In Sung Park; Young Seok Lee
Journal:  Korean J Neurotrauma       Date:  2019-09-18

6.  Cervical Spinal Fracture Caused by Untreated Tourette Syndrome: A Case Report.

Authors:  Changgon Kim; Byeong Sam Choi; Hae Yu Kim; Sungjoon Lee
Journal:  Korean J Neurotrauma       Date:  2020-08-31

7.  New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6.

Authors:  Rafael Garcia-Lopez; Emilio Perea-Milla; Cesar Ruiz Garcia; Francisco Rivas-Ruiz; Julio Romero-Gonzalez; Jose L Moreno; Vicente Faus; Guadalupe del Castillo Aguas; Juan C Ramos Diaz
Journal:  Trials       Date:  2009-03-10       Impact factor: 2.279

Review 8.  Tourette Syndrome Treatment Updates: a Review and Discussion of the Current and Upcoming Literature.

Authors:  Jessica Frey; Irene A Malaty
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.